Current and future economic burden of osteoporosis in New Zealand

Applied Health Economics and Health Policy

Volumn 9, Issue 2, 2011, Pages 111-123

  Brown, Paul ^a   McNeill, Rob ^a   Leung, William ^a   Radwan, Eman ^b   Willingale, Jane ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b WAITEMATA DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

Cost of illness; Osteoporosis treatment; Quality adjusted life years

Indexed keywords

ALENDRONIC ACID; CALCITRIOL; CALCIUM CARBONATE; CALCIUM LACTATE; ETIDRONIC ACID; GLUCONATE CALCIUM; VITAMIN D;

ADULT; AGED; ARTICLE; DRUG COST; FEMALE; HEALTH CARE COST; HEALTH SERVICE; HIP FRACTURE; HOSPITALIZATION; HUMAN; HUMERUS FRACTURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEW ZEALAND; OSTEOPOROSIS; PELVIS FRACTURE; QUALITY OF LIFE; VERTEBRA FRACTURE; VITAMIN SUPPLEMENTATION;

CENSUSES; FORECASTING; HEALTH CARE COSTS; HIP FRACTURES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NEW ZEALAND; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; QUALITY-ADJUSTED LIFE YEARS; SPINAL FRACTURES;

EID: 79951902284     PISSN: 11755652     EISSN: 11791896     Source Type: Journal    
DOI: 10.2165/11531500-000000000-00000     Document Type: Article

References (37)

1. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006 Dec; 17 (12): 1726-33 (Pubitemid 44607392)
2. WHO. Prevention and management of osteoporosis: report of a WHO Scientific Group. Geneva: WHO, 2003. WHO Technical Report Series 921
3. Kanis JA, Oden A, Johnell O, et al. The burden of osteoporotic fractures: a method for setting intervention thresholds. Osteoporos Int 2001; 12 (5): 417-27 (Pubitemid 32606468)
4. Jones G, Nguyen T, Sambrook PN, et al. Symptomatic fracture incidence in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES). Osteoporos Int 1994 Sep; 4 (5): 277-82 (Pubitemid 24291436)
5. Rabenda V, Manette C, Lemmens R, et al. Prevalence and impact of osteoarthritis and osteoporosis on health-related quality of life among active subjects. Aging Clin Exp Res 2007 Feb; 19 (1): 55-60 (Pubitemid 46534222)
6. Pasco JA, Sanders KM, Hoekstra FM, et al. The human cost of fracture. Osteoporos Int 2005; 16: 2046-52 (Pubitemid 41790926)
7. Taylor BC, Schreiner PJ, Stone KL, et al. Long-term prediction of incident hip fracture risk in elderly white women: study of osteoporotic fractures. J Am Geriatr Soc 2004 Sep; 52 (9): 1479-86 (Pubitemid 39209595)
8. Access Economics PL. The burden of brittle bones: costing osteoporosis in Australia. Canberra (ACT): Osteoporosis Australia, 2001 Sep
9. Kanis JA, Oden A, Johnell O, et al. The components of excess mortality after hip fracture. Bone 2003 May; 32 (5): 468-73 (Pubitemid 39665705)
10. Gold DT, Solimeo S. Osteoporosis and depression: a historical perspective. Curr Osteoporos Rep 2006 Dec; 4 (4): 134-9 (Pubitemid 46030450)
11. Pongchaiyakul C, Nguyen ND, Jones G, et al. Asymptomatic vertebral deformity as a major risk factor for subsequent fractures and mortality: a long-term prospective study. J Bone Miner Res 2005; 20 (8): 1349-55 (Pubitemid 41033519)
12. Lane A. Direct costs of osteoporosis for New Zealand women. Pharmacoeconomics 1996 Mar; 9 (3): 231-45 (Pubitemid 26088910)
13. PHARMAC. Zoledronic acid funded for osteoporosis [press release]. 2010 Aug 25 [online]. Available from URL: http:// www.pharmac.govt.nz/2010/08/25/ Zoledronic%20fund.pdf/text [Accessed 2010 Nov 18]
14. Metcalf S, Wilkinson T, Rasiah D. PHARMAC responds on agents to prevent osteoporotic fractures. N Z Med J 2006 Mar 10; 119 (1230): U1895
15. Statistics New Zealand. Population projections [online]. Available from URL: http://www.stats.govt.nz/browse-for- stats/population/estimates-and- projections/demographictrends- 2005.aspx [Accessed 2007 Mar 14]
16. Ministry of Health. New Zealand Health Information Service. National minimum dataset (hospital events). 2007 [online]. Available from URL: http://www.nzhis.govt.nz/moh.nsf/pagesns/238 [Accessed 2010 Nov 18]
17. Cummings SR, Kelsey JL, Nevitt MC, et al. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985; 7: 178-208 (Pubitemid 15236006)
18. Zethraeus N, Borgstrom F, Strom O, et al. Cost-effectiveness of the treatment and prevention of osteoporosis: a review of the literature and a reference model. Osteoporos Int 2007 Jan; 18 (1): 9-23 (Pubitemid 44885492)
19. Kanis JA, Oden A, Johnell O, et al. Excess mortality after hospitalisation for vertebral fracture. Osteoporos Int 2004 Feb; 15 (2): 108-12 (Pubitemid 38252423)
20. Dolan P, Torgerson DJ. The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporos Int 1998; 8 (6): 611-7 (Pubitemid 28566979)
21. Kanis JA, Borgstrom F, Zethraeus N, et al. Intervention thresholds for osteoporosis in the UK. Bone 2005; 36: 22-32 (Pubitemid 40128271)
22. Center JR, Nguyen TV, Schneider D, et al. Mortality after allmajor types of osteoporotic fracture inmen and women: an observational study. Lancet 1999 Mar 13; 353 (9156): 878-82 (Pubitemid 29126875)
23. Kanis JA, Johnell O, Oden A, et al. The risk and burden of vertebral fractures in Sweden.Osteoporos Int 2004; 15 (1): 20-6 (Pubitemid 38252435)
24. Data on file, Auckland District Health Board, 2007 Apr 15
25. Finnern HW, Sykes DP. The hospital cost of vertebral fractures in the EU: estimates using national datasets. Osteoporos Int 2003 Jun; 14 (5): 429-36 (Pubitemid 36919225)
26. Schwenkglenks M, Lippuner K, Hauselmann HJ, et al. A model of osteoporosis impact in Switzerland 2000-2020. Osteoporos Int 2005; 16: 659-71
27. Kanis JA, Brazier JE, Stevenson M, et al. Treatment of established osteoporosis: a systematic review and cost-utility analysis. Health Technol Assess 2002; 6 (29): 1-146
28. Burge RT, King AB, Balda E, et al. Methodology for estimating current and future burden of osteoporosis is state populations: application to Florida in 2000 through 2025. Value Health 2003; 6 (5): 574-83 (Pubitemid 37187720)
29. Ministry of Health. New Zealand health survey (2002/2003) [online]. Available from URL: http://www.nhc.health. govt.nz/moh.nsf/indexmh/ dataandstatistics-survey-nzhealth [Accessed 2010 Nov 18]
30. Statistics New Zealand. Census of population and dwellings 2001 [online]. Available from URL: http://www.stats. govt.nz/census.aspx [Accessed 2010 Nov 18]
31. Publicly funded pharmaceutical usage data for New Zealand. Wellington: New Zealand Health Information Service, 2007 Jun 17. (Data on file)
32. New ZealandMinistry of Health. Evidence-based health objectives for the New Zealand health strategy. Public health intelligence, occasional bulletin no. 2. Wellington:Ministry of Health, 2001Mar [online]. Available from URL: http://www. moh.govt.nz/moh.nsf/pagesmh/579 [Accessed 2007 Mar 12]
33. Orsini LS, RouscupM, Long S, et al. Health care utilization and expenditures in the United States: a study of osteoporosisrelated fractures. Osteoporos Int 2005; 16: 359-71 (Pubitemid 40487393)
34. Jonsson B, Christiansen C, Johnell O, et al. Cost effectiveness of fracture prevention in established osteoporosis. Scand J Rheumatol 1996; 103 (Suppl.): 30-8 (Pubitemid 126716948)
35. Levy P, Levy E, Audran M, et al. The cost of osteoporosis in men: the French situation. Bone 2002 Apr; 30 (4): 631-6 (Pubitemid 34270503)
36. Brown JP, Josse RG, Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada [published erratumappears in CMAJ 2003 Feb 18; 168 (4): 400]. CMAJ 2002 Nov 12; 167 (10 Suppl.): S1-34 (Pubitemid 35365303)
37. Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int 1997; 7 (5): 407-13 (Pubitemid 27443065)